223 related articles for article (PubMed ID: 16211238)
21. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
23. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
25. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
26. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation.
Rok P; Kasprzyk-Obara J; Domańska-Pakieła D; Jóźwiak S
Med Sci Monit; 2005 May; 11(5):CR230-234. PubMed ID: 15874888
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
[TBL] [Abstract][Full Text] [Related]
28. Tuberin activates the proapoptotic molecule BAD.
Freilinger A; Rosner M; Krupitza G; Nishino M; Lubec G; Korsmeyer SJ; Hengstschläger M
Oncogene; 2006 Oct; 25(49):6467-79. PubMed ID: 16702951
[TBL] [Abstract][Full Text] [Related]
29. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
Jansen FE; Braams O; Vincken KL; Algra A; Anbeek P; Jennekens-Schinkel A; Halley D; Zonnenberg BA; van den Ouweland A; van Huffelen AC; van Nieuwenhuizen O; Nellist M
Neurology; 2008 Mar; 70(12):908-15. PubMed ID: 18032745
[TBL] [Abstract][Full Text] [Related]
30. Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations.
Yamashita Y; Ono J; Okada S; Wataya-Kaneda M; Yoshikawa K; Nishizawa M; Hirayama Y; Kobayashi E; Seyama K; Hino O
Am J Med Genet; 2000 Jan; 90(2):123-6. PubMed ID: 10607950
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.
Xu Z; Wang M; Wang L; Wang Y; Zhao X; Rao Q; Wang J
Leuk Res; 2009 Jul; 33(7):891-7. PubMed ID: 19250671
[TBL] [Abstract][Full Text] [Related]
32. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
[TBL] [Abstract][Full Text] [Related]
33. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
Nellist M; Burgers PC; van den Ouweland AM; Halley DJ; Luider TM
Biochem Biophys Res Commun; 2005 Aug; 333(3):818-26. PubMed ID: 15963462
[TBL] [Abstract][Full Text] [Related]
35. Generation of a conditional disruption of the Tsc2 gene.
Hernandez O; Way S; McKenna J; Gambello MJ
Genesis; 2007 Feb; 45(2):101-6. PubMed ID: 17245776
[TBL] [Abstract][Full Text] [Related]
36. The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment.
de Vries PJ; Howe CJ
Trends Mol Med; 2007 Aug; 13(8):319-26. PubMed ID: 17632034
[TBL] [Abstract][Full Text] [Related]
37. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38.
Rosner M; Hofer K; Kubista M; Hengstschläger M
Oncogene; 2003 Jul; 22(31):4786-98. PubMed ID: 12894220
[TBL] [Abstract][Full Text] [Related]
38. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
39. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations in 21 patients with tuberous sclerosis complex and variation of tandem splice-acceptor sites in TSC1 exon 14.
Sasongko TH; Wataya-Kaneda M; Koterazawa K; Gunadi ; Yusoff S; Harahap IS; Lee MJ; Matsuo M; Nishio H
Kobe J Med Sci; 2008 May; 54(1):E73-81. PubMed ID: 18772611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
